Assessment of Anti-SARS CoV-2 seroprevalence in habitants of Assam (AASSHA): report of the first serosurvey in Assam


  • Jyotismita Pathak Head, Policy and Program, Srijanasom, Assam, India
  • Mridusmita Das Managing Trustee, Srijansom, Assam, India
  • Khalil Siddique Director, Aditya Medicity Guwahati, Assam, India



Serosurvey, COVID-19, Assam, SARS-CoV-2


Background: Today, there is a pressing need to identify the proportion of people immune to the infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) so that public health policies can be formulated accordingly for the ongoing COVID-19 pandemic. Keeping this in mind, we designed a serosurvey in Assam with aims to estimate the prevalence of infection as well as the infection to case ratio of the novel coronavirus in Assam.

Methods: A total of 9 districts belonging to three different strata of districts were randomly selected for the study. In these selected districts, blood samples were collected from a sample of population and were checked for the antibodies (IgG type). Those testing reactive for the mentioned antibodies were considered to have been infected ever before the onset of the study.

Results: A total of 2390 study subjects were tested for the presence of antibodies against the SARS-CoV-2. The proportion of people harboring antibodies against the infection was found to be 23.7 percent.

Conclusions: The serosurvey revealed that the proportion of people having antibodies was lower than that required for attaining herd immunity levels in a population. The case to infection ratios reveal that there is a large chunk of population who didn’t know about their infection.


WHO Coronavirus Disease (COVID-19) Dashboard. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: Accessed on 26 July 2020.

Coronavirus in India: Latest Map and Case Count. Available at: Accessed on 26 July 2020.

Centre NI. Covid 19 Dashboard – Government of Assam. Available at: Accessed on 26 July 2020.

Why is it difficult to accurately predict the COVID-19 epidemic? Available at: https://www.ncbi. Accessed on 26 July 2020.

Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet. 2020;396(10247):313-9.

Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020;152(1,2):48-60.

Indian Council of Medical Research, Department of Health Research-Press Release. Available at: Accessed on 27 July 2020.

Updates on COVID-19. Available at: Accessed on 27 July 2020.

List of states with Population, Sex Ratio and Literacy Census 2011. Available at: https://www.census2011. Accessed on 27 July 2020.

Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nature Rev Immunol. 2020;20(10):583-4.

Rane TM, Mahanta TG, Islam S, Gogoi PP, Gogoi B. Civil registration system (CRS) for birth and death registration in Assam – A rapid assessment. Clin Epidemiol Global Health. 2020;8(1):117-22.




How to Cite

Pathak, J., Das, M., & Siddique, K. (2021). Assessment of Anti-SARS CoV-2 seroprevalence in habitants of Assam (AASSHA): report of the first serosurvey in Assam. International Journal Of Community Medicine And Public Health, 8(5), 2490–2496.



Original Research Articles